206 related articles for article (PubMed ID: 11709805)
1. Aldosterone in progressive renal disease.
Hostetter TH; Rosenberg ME; Ibrahim HN; Juknevicius I
Semin Nephrol; 2001 Nov; 21(6):573-9. PubMed ID: 11709805
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone in renal disease.
Hostetter TH; Rosenberg ME; Ibrahim HN; Juknevicius I
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):105-10. PubMed ID: 11195042
[TBL] [Abstract][Full Text] [Related]
3. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
Weinberg MS; Weinberg AJ; Zappe DH
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
[No Abstract] [Full Text] [Related]
4. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
Ibrahim HN; Rosenberg ME; Hostetter TH
Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
[TBL] [Abstract][Full Text] [Related]
5. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
6. Novel aspects of the renin-angiotensin-aldosterone-system.
Wolf G
Front Biosci; 2008 May; 13():4993-5005. PubMed ID: 18508564
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
8. A clinical approach in regression of glomerulosclerosis.
Stoian M; Radulian G; ChiĊ£ac D; Simion E; Stoica V
Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone in renal disease.
Ibrahim HN; Hostetter TH
Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):159-64. PubMed ID: 12589176
[TBL] [Abstract][Full Text] [Related]
11. How does angiotensin II cause renal injury?
Long DA; Price KL; Herrera-Acosta J; Johnson RJ
Hypertension; 2004 Apr; 43(4):722-3. PubMed ID: 14967828
[No Abstract] [Full Text] [Related]
12. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.
Black HR
Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone is a major factor in the progression of renal disease.
Ibrahim HN; Rosenberg ME; Greene EL; Kren S; Hostetter TH
Kidney Int Suppl; 1997 Dec; 63():S115-9. PubMed ID: 9407437
[TBL] [Abstract][Full Text] [Related]
14. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.
Brunner HR
Am J Cardiol; 2001 Apr; 87(8A):3C-9C. PubMed ID: 11334762
[TBL] [Abstract][Full Text] [Related]
15. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic measures in proteinuric nephropathy.
Praga M
Kidney Int Suppl; 2005 Dec; (99):S137-41. PubMed ID: 16336567
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin-aldosterone system and heart failure.
Sayer G; Bhat G
Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift.
Epstein M
J Hypertens; 2001 May; 19(5):829-42. PubMed ID: 11393664
[TBL] [Abstract][Full Text] [Related]
20. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.
Remuzzi G; Perico N; Macia M; Ruggenenti P
Kidney Int Suppl; 2005 Dec; (99):S57-65. PubMed ID: 16336578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
